Scipher Medicine

Scipher Medicine is a precision immunology company matching patients with the most effective treatments. The company believes that based on scientific data, patients should receive straightforward treatment answers. Using our proprietary network drug platform Spectra™, we uncover tests that reveal a patient’s unique molecular disease signature and match it with the most effective therapy, ensuring the best treatment from day one. Patient molecular data generated from our tests further supports the discovery and development of new and more effective treatments. We have developed PrismRA®, a first-of-its-kind blood test that predicts which rheumatoid arthritis patients are unlikely to respond to TNFi therapies such as Humira® and Enbrel®, allowing these patients to proceed with approved alternative medications. We collaborate with leading payers, healthcare providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases.